DM1

Clinical trials for DM1 explained in plain language.

Never miss a new study

Get alerted when new DM1 trials appear

Sign up with your email to follow new studies for DM1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1 Completed 3

New hope for DM1: Long-Term trial of AOC 1001 underway

Disease control By invitation only

This phase 3 study is testing the long-term safety and effectiveness of an experimental drug called AOC 1001 (del-desiran) for people with myotonic dystrophy type 1 (DM1), a genetic muscle disorder. The trial enrolls 230 adults who have completed a prior AOC 1001 study and will r…

Matched conditions: DM1

Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC

DM1

Get alerted when new DM1 trials appear

New hope for DM1: Long-Term trial of AOC 1001 underway